-
US has already had more measles cases in 2024 than all of 2023CDC data shows that more than 60 measles cases have been reported so far in 2024, surpassing last year's total.
-
RSV vaccine keeps older adults highly protected for at least 2 seasonsPfizer's recently approved RSV vaccine maintains a high and fairly steady rate of effectiveness across consecutive RSV seasons.
-
Rare clotting effect of early COVID shots finally explained — what could that mean for future vaccines?Scientists have offered a new explanation for why COVID-19 vaccines that contained adenoviruses carried a rare-but-serious risk of blood clotting.
-
Vaccine for superbugs? New shot shows promise in early testsA new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.
-
Measles deaths jumped over 40% from 2021 to 2022, CDC reportsDeclines in measles vaccination during the COVID-19 pandemic have been tied to an uptick in measles cases, deaths and major outbreaks worldwide.
-
FDA approves world's 1st chikungunya vaccineThere's now an FDA-approved vaccine for chikungunya, a mosquito-spread virus that can cause fever, severe joint pain, and rarely, death.
-
Who should get the new COVID vaccines? What to know about the 2023-2024 shotsNew COVID vaccines have been approved to guard against coronavirus variants that are currently circulating.
-
Novavax's new COVID vaccine cleared for use by FDAAn updated COVID-19 vaccine made by Novavax has been authorized by the FDA, joining the two vaccines already cleared for use.
-
Inexpensive new malaria vaccine is a 'vital tool' to protect tens of millions of peopleThe World Health Organization has recommended the use of a malaria vaccine called Matrix-M, which is anticipated to boost the vaccine supply.
